Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SarCaBon: Saracatinib for Cancer-induced Bone Pain
NCT02085603Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Mar 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in cancer-induced bone pain (CIBP), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Mar 2014; status: completed.
02
Drugs
saracatinib
03
Conditions
cancer-induced bone pain (CIBP)
Beyond the preview
Go deeper on NCT02085603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085603.